WuXi Biologics (Cayman), Inc. (WXIBF)
WuXi Biologics Market Cap: 16.42B for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| China Pharma Holdings, Inc. | 5.480M |
| CASI Pharmaceuticals, Inc. | 17.13M |
| Zai Lab Ltd. | 2.024B |
| Adagene, Inc. | 85.27M |
Market Cap Related Metrics
| PE Ratio | 29.53 |
| PS Ratio | 6.098 |
| Price to Free Cash Flow | 61.33 |
| Price | 4.04 |
| Earnings Yield | 3.39% |
| Operating PE Ratio | 22.28 |
| Normalized PE Ratio | 31.39 |